Biogenesis of Small Rnas in Animals
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Epigenetic Roles of PIWI‑Interacting Rnas (Pirnas) in Cancer Metastasis (Review)
ONCOLOGY REPORTS 40: 2423-2434, 2018 Epigenetic roles of PIWI‑interacting RNAs (piRNAs) in cancer metastasis (Review) JIA LIU1, SHUJUN ZHANG2 and BINGLIN CHENG1 1Department of Integrated Traditional Chinese and Western Medicine Oncology, The First Affiliated Hospital of Harbin Medical University; 2Department of Pathology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, P.R. China Received March 19, 2018; Accepted September 3, 2018 DOI: 10.3892/or.2018.6684 Abstract. P-element-induced wimpy testis (PIWI)-interacting 7. Epigenetics of ncRNAs in cancer RNAs (piRNAs) are epigenetic-related short ncRNAs that 8. Discussion participate in chromatin regulation, transposon silencing, and modification of specific gene sites. These epigenetic factors or alterations are also involved in the growth of a variety 1. Introduction of human cancers, including lung, breast, and colon cancer. Accumulating evidence has revealed that tumor metastasis P-element-induced wimpy testis (PIWI)-interacting RNAs and invasion involve genetic and epigenetic factors. Cancer (piRNAs) belong to a new class of ncRNAs that have been asso- metastasis is characterized by epigenetic alterations including ciated with many cancers (1). piRNAs are involved in the gene DNA methylation and histone modification. Changes in DNA regulation process in which certain nucleotides bind coding methylation, H3K9me3 heterochromatin and transposable regions in gene promoters (2). piRNAs function in the epigen- elements have been detected in several cancers. piRNAs may etic regulation of DNA methylation (3), transposable silencing function in gene silencing and gene modification upstream and chromatin modification (4). PIWI is a type of Argonaute or downstream of oncogenes in cancer cell lines or cancer protein that binds to piRNAs and carries out unique functions tissues. -
Patenting Interfering RNA
Patenting Interfering RNA J. Douglas Schultz SPE Art Unit 1635 (571) 272-0763 [email protected] Oligonucleotide Inhibitors: Mechanisms of Action RNAi - Mechanism of Action • dsRNA induces sequence-specific degradation of homologous gene transcripts • RISC metabolizes dsRNA to small 21-23- nucleotide siRNAs – RISC contains dsRNase (“Dicer”), ssRNase (Argonaut 2 or Ago2) • RISC utilizes antisense strand as “guide” to find cleavable target siRNA Mechanism of Action miRNA Mechanism of Action Interfering RNA Glossary of Terms • RNAi – RNA interference • dsRNA – double stranded RNA • siRNA – small interfering RNA, double stranded, 21-23 nucleotides • shRNA – short hairpin RNA (doubled stranded by virtue of a ssRNA folding back on itself) • miRNA – micro RNA • RISC – RNA-induced silencing complex – Dicer – RNase endonuclease siRNA miRNA • Exogenously delivered • Endogenously produced • 21-23mer dsRNA • 21-23mer dsRNA • Acts through RISC • Acts through RISC • Induces homologous target • Induces homologous target cleavage cleavage • Perfect sequence match • Imperfect sequence match – Results in target degradation – Results in translation arrest RNAi Patentability issues Sample Claims: • A siRNA that inhibits expression of a nucleic acid encoding protein X. OR • A siRNA comprising a 2’-modification, wherein said modification comprises 2’-fluoro, 2’-O-methyl, or 2’- deoxy. (Note: no target recited) OR • A method of reducing tumor cell growth comprising administering siRNA targeting protein X. RNAi Patentability Issues 35 U.S.C. 101 – Utility • Credible/Specific/Substantial/Well Established. • Used to attempt modulation of gene expression in human diseases • Routinely investigate gene function in a high throughput fashion or to (see Rana RT, Nat. Rev. Mol. Cell Biol. 2007, Vol. 8:23-36). -
(12) Patent Application Publication (10) Pub. No.: US 2004/0086860 A1 Sohail (43) Pub
US 20040O86860A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0086860 A1 Sohail (43) Pub. Date: May 6, 2004 (54) METHODS OF PRODUCING RNAS OF Publication Classification DEFINED LENGTH AND SEQUENCE (51) Int. Cl." .............................. C12Q 1/68; C12P 19/34 (76) Inventor: Muhammad Sohail, Marston (GB) (52) U.S. Cl. ............................................... 435/6; 435/91.2 Correspondence Address: MINTZ, LEVIN, COHN, FERRIS, GLOWSKY (57) ABSTRACT AND POPEO, PC. ONE FINANCIAL CENTER Methods of making RNA duplexes and single-stranded BOSTON, MA 02111 (US) RNAS of a desired length and Sequence based on cleavage of RNA molecules at a defined position, most preferably (21) Appl. No.: 10/264,748 with the use of deoxyribozymes. Novel deoxyribozymes capable of cleaving RNAS including a leader Sequence at a (22) Filed: Oct. 4, 2002 Site 3' to the leader Sequence are also described. Patent Application Publication May 6, 2004 Sheet 1 of 2 US 2004/0086860 A1 DNA Oligonucleotides T7 Promoter -TN-- OR 2N-2-N-to y Transcription Products GGGCGAAT-N-UU GGGCGAAT-N-UU w N Deoxyribozyme Cleavage - Q GGGCGAAT -------' Racction GGGCGAAT N-- UU N-UU ssRNA products N-UU Anneal ssRNA UU S-2N- UU siRNA product FIGURE 1: Flowchart summarising the procedure for siRNA synthesis. Patent Application Publication May 6, 2004 Sheet 2 of 2 US 2004/0086860 A1 Full-length transcript 3'-digestion product 5'-digestion product (5'GGGCGAATA) A: Production of single-stranded RNA templates by in vitro transcription and digestion With a deoxyribozyme V 2- 2 V 22inv 22 * 2 &3 S/AS - 88.8x, *...* or as IGFR -- is as 4. -
INTRODUCTION Sirna and Rnai
J Korean Med Sci 2003; 18: 309-18 Copyright The Korean Academy ISSN 1011-8934 of Medical Sciences RNA interference (RNAi) is the sequence-specific gene silencing induced by dou- ble-stranded RNA (dsRNA). Being a highly specific and efficient knockdown tech- nique, RNAi not only provides a powerful tool for functional genomics but also holds Institute of Molecular Biology and Genetics and School of Biological Science, Seoul National a promise for gene therapy. The key player in RNAi is small RNA (~22-nt) termed University, Seoul, Korea siRNA. Small RNAs are involved not only in RNAi but also in basic cellular pro- cesses, such as developmental control and heterochromatin formation. The inter- Received : 19 May 2003 esting biology as well as the remarkable technical value has been drawing wide- Accepted : 23 May 2003 spread attention to this exciting new field. V. Narry Kim, D.Phil. Institute of Molecular Biology and Genetics and School of Biological Science, Seoul National University, San 56-1, Shillim-dong, Gwanak-gu, Seoul 151-742, Korea Key Words : RNA Interference (RNAi); RNA, Small interfering (siRNA); MicroRNAs (miRNA); Small Tel : +82.2-887-8734, Fax : +82.2-875-0907 hairpin RNA (shRNA); mRNA degradation; Translation; Functional genomics; Gene therapy E-mail : [email protected] INTRODUCTION established yet, testing 3-4 candidates are usually sufficient to find effective molecules. Technical expertise accumulated The RNA interference (RNAi) pathway was originally re- in the field of antisense oligonucleotide and ribozyme is now cognized in Caenorhabditis elegans as a response to double- being quickly applied to RNAi, rapidly improving RNAi stranded RNA (dsRNA) leading to sequence-specific gene techniques. -
Piwi-Interacting Rnas and PIWI Genes As Novel Prognostic Markers for Breast Cancer
www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 25 Research Paper Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer Preethi Krishnan1, Sunita Ghosh2,3, Kathryn Graham2,3, John R. Mackey2,3, Olga Kovalchuk4, Sambasivarao Damaraju1,3 1Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada 2Department of Oncology, University of Alberta, Edmonton, Alberta, Canada 3Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada 4Department of Biological Sciences, University of Lethbridge, Lethbridge, Alberta, Canada Correspondence to: Sambasivarao Damaraju, email: [email protected] Keywords: piRNA, PIWI, breast cancer, prognostic marker, TCGA Received: January 13, 2016 Accepted: April 28, 2016 Published: May 10, 2016 ABSTRACT Piwi-interacting RNAs (piRNAs), whose role in germline maintenance has been established, are now also being classified as post-transcriptional regulators of gene expression in somatic cells. PIWI proteins, central to piRNA biogenesis, have been identified as genetic and epigenetic regulators of gene expression. piRNAs/PIWIs have emerged as potential biomarkers for cancer but their relevance to breast cancer has not been comprehensively studied. piRNAs and mRNAs were profiled from normal and breast tumor tissues using next generation sequencing and Agilent platforms, respectively. Gene targets for differentially expressed piRNAs were identified from mRNA expression dataset. piRNAs and PIWI genes were independently assessed for their prognostic significance (outcomes: Overall Survival, OS and Recurrence Free Survival, RFS). We discovered eight piRNAs as novel independent prognostic markers and their association with OS was confirmed in an external dataset (The Cancer Genome Atlas). Further, PIWIL3 and PIWIL4 genes showed prognostic relevance. 306 gene targets exhibited reciprocal relationship with piRNA expression. -
Small Interfering RNA-Mediated Translation Repression Alters Ribosome Sensitivity to Inhibition by Cycloheximide in Chlamydomonas Reinhardtii
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Dissertations and Theses in Biological Sciences Biological Sciences, School of Spring 2013 Small Interfering RNA-Mediated Translation Repression Alters Ribosome Sensitivity to Inhibition by Cycloheximide in Chlamydomonas reinhardtii Xinrong Ma University of Nebraska-Lincoln, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/bioscidiss Part of the Biology Commons, Cellular and Molecular Physiology Commons, Microbiology Commons, and the Molecular Genetics Commons Ma, Xinrong, "Small Interfering RNA-Mediated Translation Repression Alters Ribosome Sensitivity to Inhibition by Cycloheximide in Chlamydomonas reinhardtii" (2013). Dissertations and Theses in Biological Sciences. 51. https://digitalcommons.unl.edu/bioscidiss/51 This Article is brought to you for free and open access by the Biological Sciences, School of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Dissertations and Theses in Biological Sciences by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. SMALL INTERFERING RNA-MEDIATED TRANSLATION REPRESSION ALTERS RIBOSOME SENSITIVITY TO INHIBITION BY CYCLOHEXIMIDE IN CHLAMYDOMONAS REINHARDTII by Xinrong Ma A DISSERTATION Presented to the Faculty of The Graduate College at the University of Nebraska In Partial Fulfillment of Requirements For the Degree of Doctor of Philosophy Major: Biological Sciences Under the Supervision of Professor Heriberto Cerutti Lincoln, Nebraska May, 2013 SMALL INTERFERING RNA-MEDIATED TRANSLATION REPRESSION ALTERS RIBOSOME SENSITIVITY TO INHIBITION BY CYCLOHEXIMIDE IN CHLAMYDOMONAS REINHARDTII Xinrong Ma, Ph.D. University of Nebraska, 2013 Advisor: Heriberto Cerutti RNA interference (RNAi) is an evolutionarily conserved gene silencing mechanism in eukaryotes, with regulatory roles in a variety of biological processes, including cell cycle, cell differentiation, physiological and metabolic pathways, and stress responses. -
Annale D890ahlfors.Pdf (5.211Mb)
TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS SARJA - SER. D OSA - TOM. 890 MEDICA - ODONTOLOGICA INTERLEUKIN-4 INDUCED LEUKOCYTE DIFFERENTIATION by Helena Ahlfors TURUN YLIOPISTO UNIVERSITY OF TURKU Turku 2009 From Turku Centre for Biotechnology, University of Turku and Åbo Akademi University; Department of Medical Biochemistry and Molecular Biology, University of Turku and National Graduate School of Informational and Structural Biology Supervised by Professor Riitta Lahesmaa, M.D., Ph.D. Turku Centre for Biotechnology University of Turku and Åbo Akademi University Turku, Finland Reviewed by Professor Risto Renkonen M.D., Ph.D. Transplantation laboratory Haartman Institute University of Helsinki Helsinki, Finland and Docent Panu Kovanen, M.D., Ph.D. Haartman Institute Department of Pathology University of Helsinki Helsinki, Finland Opponent Assistant Professor Mohamed Oukka, Ph.D. Seattle Children’s Research Institute Department of Immunology University of Washington Seattle, USA ISBN 978-951-29-4183-4 (PRINT) ISBN 978-951-29-4184-1 (PDF) ISSN 0355-9483 Painosalama Oy – Turku, Finland 2009 Think where mans glory most begins and ends, and say my glory was I had such friends. William Butler Yeats (1865 – 1939) ABSTRACT Helena Ahlfors Interleukin-4 induced leukocyte differentiation Turku Centre for Biotechnology, University of Turku and Åbo Akademi University Department of Medical Biochemistry and Genetics, University of Turku National Graduate School of Informational and Structural Biology, 2009 Monocytes, macrophages and dendritic cells (DCs) are important mediators of innate immune system, whereas T lymphocytes are the effector cells of adaptive immune responses. DCs play a crucial role in bridging innate and adaptive immunity. Naïve CD4+ Th progenitors (Thp) differentiate to functionally distinct effector T cell subsets including Th1, Th2 and Th17 cells, which while being responsible for specific immune functions have also been implicated in pathological responses, such as autoimmunity, asthma and allergy. -
HISTORY and ANALYSIS of the CREATION RESEARCH SOCIETY by William E
AN ABSTRACT OF THE THESIS OF William E. Elliott for the degree ofMaster of Science in General Science presented on March 1, 1990. Title: History and Analysis of theCreation ltee Society Redacted for Privacy Abstractapproved: The resurgence of creationismthe past few years has been led by advocates of recent-creationism. These individuals, a minority among creationists in general, argue that the entire universe was created approximately 10,000 years ago in one six- day period of time.Recent-creationists support their position by appealing to the Genesis account of creation and scientific data. Their interpretation of Genesis is based on the doctrines of conservative, evangelical Christianity. Their interpretation of scientific data is informed by their theological presuppositions. The scientific side of recent-creationism is supported by several organizations, most of which had their origin in one group, the Creation Research Society. The CRS is a major factor in the rise of the modern creationist movement. Founded in 1963, this small (c. 2000 mem- bers) group claims to be a bona-fide scientific society engaged in valid scientific re- search conducted from a recent-creationist perspective. These claims are analyzed and evaluated. The Society's history is discussed, including antecedent creationist groups. Most of the group's founders were members of the American Scientific Affiliation, and their rejection of changes within the ASA was a significant motivating factor in founding the CRS. The organization, functioning, and finances of the Society are de- tailed with special emphasis on the group's struggles for independence and credibility. founding the CRS. The organization, functioning, and finances of the Society are de- tailed with special emphasis on the group's struggles for independence and credibility. -
Science Destroys the Evolutionary Paradigm
SCIENCE DESTROYS THE EVOLUTIONARY PARADIGM An Inservice Manual for Young-Earth Creationists Free Images – Snappygoat.com Materialistic Naturalism, an Immoral and Incoherent Philosophy!!! Dr. Jim Pagels – 4/18/2018 1 For as the heavens are higher than the earth, so are my ways higher than your ways and my thoughts than your thoughts. For as the rain and the snow come down from heaven and do not return there but water the earth, making it bring forth and sprout, giving seed to the sower and bread to the eater, so shall my word be that goes out from my mouth; it shall not return to me empty, but it shall accomplish that which I purpose, and shall succeed in the thing for which I sent it. Isaiah 55:9-11 This book along with its predecessors including Apologetic Resources, Lesson Plans for Biblical Apologetics and Touching Lives through Apologetics, a Counseling Perspective are offered free for personal and professional use in ministry, being available as downloads on the Michigan District website under schools-curriculum. Scriptural references are typically taken from the English Standard Version (ESV) although the King James Version (KJV) is also periodically utilized. 2 Contents Acknowledgements………………………………………………………………………..…….5 Preface…………………………………………………………………………………………...6 Intended Audience ……………………………………………………………………………....8 Inservice Perspective……….…………………………………………………………….……..9 Inservice Questionnaire……………………………………………………………..…………10 1. Evolution, an Attack on the Supernatural Nature of God…………………………………..21 2. In Search of Truth…………………………………………………………………………..23 3. Creation Apologetics, Simple for Some, Incomprehensible to Others………..……..…….35 4. Two Typical Approaches to Young Earth Creationism……………………………………38 5. The Absolute Veracity of the Supernatural…………………….…………………………..40 6. A Tactical Approach to Creationism………………………….………………………..…..43 7. -
Retroviral Delivery of Small Interfering RNA Into Primary Cells
Retroviral delivery of small interfering RNA into primary cells Gregory M. Barton and Ruslan Medzhitov* Section of Immunobiology and The Howard Hughes Medical Institute, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06520 Communicated by Peter Cresswell, Yale University School of Medicine, New Haven, CT, October 2, 2002 (received for review August 9, 2002) RNA interference is an evolutionarily conserved process in which gene was replaced with the human CD4 gene, which was cloned recognition of double-stranded RNA ultimately leads to posttran- from splenic cDNA. To eliminate any potential signaling, a scriptional suppression of gene expression. This suppression is premature stop codon was introduced after amino acid 425, just mediated by short (21- to 22-nt) small interfering RNAs (siRNAs), after the transmembrane domain. The human H1 promoter was which induce degradation of mRNA based on complementary base cloned from genomic DNA and inserted either upstream of the pairing. The silencing of gene expression by siRNAs is emerging cytomegalovirus (CMV) promoter (RVH1) by using previously rapidly as a powerful method for genetic analysis. Recently, several introduced XhoI and EcoRI sites or within the 3Ј LTR by groups have reported systems designed to express siRNAs in using SalI. The oligonucleotides encoding the human p53 mammalian cells through transfection of either oligonucleotides or siRNA, described by Brummelkamp et al. (6), were 5Ј-GATC- plasmids encoding siRNAs. Because these systems rely on trans- CCCGACTCCAGTGGTAATCTACTTCAAGAGAGTA- fection for delivery, the cell types available for study are restricted GATTACCACTGGAGTCTTTTTGGAAC-3Ј and 5Ј-TCGA- generally to transformed cell lines. Here, we describe a retroviral GTTCCAAAAAGACTCCAGTGGTAATCTACTCTCTTG- system for delivery of siRNA into cells. -
Viral Vectors Applied for Rnai-Based Antiviral Therapy
viruses Review Viral Vectors Applied for RNAi-Based Antiviral Therapy Kenneth Lundstrom PanTherapeutics, CH1095 Lutry, Switzerland; [email protected] Received: 30 July 2020; Accepted: 21 August 2020; Published: 23 August 2020 Abstract: RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic applications against viral diseases. Bioinformatics has played an important role in the design of efficient RNAi sequences targeting various pathogenic viruses. However, stability and delivery of RNAi molecules have presented serious obstacles for reaching therapeutic efficacy. For this reason, RNA modifications and formulation of nanoparticles have proven useful for non-viral delivery of RNAi molecules. On the other hand, utilization of viral vectors and particularly self-replicating RNA virus vectors can be considered as an attractive alternative. In this review, examples of antiviral therapy applying RNAi-based approaches in various animal models will be described. Due to the current coronavirus pandemic, a special emphasis will be dedicated to targeting Coronavirus Disease-19 (COVID-19). Keywords: RNA interference; shRNA; siRNA; miRNA; gene silencing; viral vectors; RNA replicons; COVID-19 1. Introduction Since idoxuridine, the first anti-herpesvirus antiviral drug, reached the market in 1963 more than one hundred antiviral drugs have been formally approved [1]. Despite that, there is a serious need for development of novel, more efficient antiviral therapies, including drugs and vaccines, which has become even more evident all around the world today due to the recent coronavirus pandemic [2]. -
Beyond Microrna Â
Cancer Letters xxx (2013) xxx–xxx Contents lists available at SciVerse ScienceDirect Cancer Letters journal homepage: www.elsevier.com/locate/canlet Mini-review Beyond microRNA – Novel RNAs derived from small non-coding RNA and their implication in cancer ⇑ Elena S. Martens-Uzunova , Michael Olvedy, Guido Jenster Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands article info abstract Article history: Over the recent years, Next Generation Sequencing (NGS) technologies targeting the microRNA transcrip- Available online xxxx tome revealed the existence of many different RNA fragments derived from small RNA species other than microRNA. Although initially discarded as RNA turnover artifacts, accumulating evidence suggests that Keywords: RNA fragments derived from small nucleolar RNA (snoRNA) and transfer RNA (tRNA) are not just random snoRNA-derived RNA (sdRNA) degradation products but rather stable entities, which may have functional activity in the normal and tRNA fragment (tRF) malignant cell. Next generation sequencing This review summarizes new findings describing the detection and alterations in expression of Cancer snoRNA-derived (sdRNA) and tRNA-derived (tRF) RNAs. We focus on the possible interactions of sdRNAs microRNA Non-coding RNA and tRFs with the canonical microRNA pathways in the cell and present current hypotheses on the func- tion of these RNAs. Ó 2013 Elsevier Ireland Ltd. All rights reserved. 1. Introduction Alongside with miRNA, other types of small regulatory ncRNAs like exogenous and endogenous small interfering RNAs (siRNAs Within less than a decade since the sequencing of the human and endo-siRNAs) [6–8] and PiWi-interacting RNAs (piRNAs) [9] genome it became clear that over ninety percent of our genes en- are also involved in gene regulation and genome defense and share code for RNA transcripts that never get translated to protein.